Akebia Therapeutics Inc (NASDAQ:AKBA)
| 0.3866 Delayed Data As of Aug 09 |  -0.0184 / -4.54%Today’s Change | 0.30 Today|||52-Week Range 3.35 | -82.89% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 49.8M | 187.3M | 70.2M | 104.6M | |
| Short Term Investment Cash | 17.0M | 137.6M | -117.2M | 35.7M | ||
| Cash & Short Term Investments | 138.5M | 260.3M | 317.8M | 321.6M | ||
| Receivables | Receivables | 0.00 | 33.8M | 34.2M | 16.7M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 114.2M | |
| Current Assets | Other Current Assets | 2.6M | 2.2M | 6.3M | 15.7M | |
| Current Assets | 141.0M | 296.3M | 358.4M | 468.3M | ||
| Total Assets | Property, Plant and Equipment - Gross | 687.0K | 3.1M | 4.7M | 10.0M | |
| Depreciation | -147.0K | -442.0K | -1.1M | -2.0M | ||
| Intangible Assets | 0.00 | 0.00 | 0.00 | 383.2M | ||
| Other Assets | 1.4M | 1.3M | 2.3M | 517.8M | ||
| Total Assets | 142.9M | 300.2M | 364.2M | 1.1B | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 0.00 | 42.8M | |
| Short Term Debt | 8.0K | 9.0K | 0.00 | 15.0M | ||
| Accrued Expenses | 6.5M | 26.1M | 45.7M | 115.2M | ||
| Other Current Liabilities | 8.9M | 110.2M | 137.6M | 195.0M | ||
| Other Liabilities | 11.9M | 114.3M | 144.3M | 265.7M | ||
| Total Liabilities | Long Term Debt | 6.0K | 5.0K | 0.00 | 0.00 | |
| Deferred Taxes | -- | -- | -- | -6.6M | ||
| Other Liabilities | 68.0K | 2.5M | 2.6M | 32.6M | ||
| Total Liabilities | 11.9M | 232.1M | 244.9M | 473.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 131.0M | 68.1M | 119.3M | 635.9M | ||
| Total Shareholder Equity | 131.0M | 68.1M | 119.3M | 635.9M | ||
| Share Information | Common Shares Outstanding | 30.7M | 38.6M | 47.6M | 116.9M | |
| Addtl. Info. | No data currently available for this section. | |||||
